MDBZP, also known as 1-(3,4-methylenedioxybenzyl)piperazine or as piperonylpiperazine, is a chemical compound of the benzylpiperazine family related to benzylpiperazine (BZP). MDBZP has been sold as a designer drug[1] and has even been found as an ingredient in street Ecstasy pills.[citation needed]
| Clinical data | |
|---|---|
| Other names | 1-(3,4-Methylenedioxybenzyl)piperazine; MDBZP; MDBP; Piperonylpiperazine; N-Piperonylpiperazine |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.046.319 |
| Chemical and physical data | |
| Formula | C12H16N2O2 |
| Molar mass | 220.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
See also
editReferences
edit- ↑ Maurer HH, Kraemer T, Springer D, Staack RF (April 2004). "Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis". Therapeutic Drug Monitoring. 26 (2): 127–31. doi:10.1097/00007691-200404000-00007. PMID 15228152. S2CID 9255084.
External links
edit- MDBZP - Isomer Design
- Expert Committee on Drug Dependence (8 June 2012). "1-(3-4-methylendioxybenzyl)piperazine (MDBZP) Pre-Review Report" (PDF). World Health Organization.